Spirit Promotion Celebrates Diversity
South Florida-based Spirit Airlines (NYSE: FLYY) is celebrating its hometown's diverse culture and culinary scene this summer with the More Fly Fort Lauderdale Flyaway, beginning today through Aug. 3. The airline is partnering with Visit Lauderdale to invite travelers across its network to enter for a chance to discover Greater Fort Lauderdale's beautiful beaches and many entertainment offerings. The sweepstakes takes place during Dine Out Lauderdale restaurant months, an incredible time for foodies to fly to Greater Fort Lauderdale and indulge in pre-fixe menus in the destination's top restaurants, including MICHELIN-recognized gems and waterfront favorites."We love to celebrate our hometown, and this new sweepstakes is a fun way to share Fort Lauderdale's incredible energy and diverse cuisines with two lucky winners," said Chief Commercial Officer Rana Ghosh. The Grand Prize winner and their guest will enjoy a roundtrip Spirit flight to Fort Lauderdale (FLL) in Spirit First,** a three-night hotel stay at The Atlantic Hotel and Spa Fort Lauderdale and delight in an oceanfront dining experience at Wild Thyme Oceanside Eatery. The First Prize winner and their guest will receive a roundtrip Spirit flight to Fort Lauderdale (FLL) in Spirit First,** a two-night hotel stay at Oceanside Fort Lauderdale Beach and enjoy a culinary experience at The Mast. FLYY shares gave up half a cent to $4.68
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


